Cutting edge: Adenovirus E19 has two mechanisms for affecting class I MHC expression

Journal of Immunology

Volumn 162, Issue 9, 1999, Pages 5049-5052

  Bennett, Elizabeth M ^a,b   Bennink, Jack R ^c   Yewdell, Jonathan W ^c   Brodsky, Frances M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INHIBITOR PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADENOVIRUS; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROTEIN DETERMINATION; VACCINIA VIRUS; VIRUS INFECTION;

ADENOVIRUS E3 PROTEINS; ADENOVIRUSES, HUMAN; ATP-BINDING CASSETTE TRANSPORTERS; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0033136705     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wold, W. S. M., and L. R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1.
2. Shisler, J., C. Yang, B. Walter, C. F. Ware, and L. R. Gooding. 1997. The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71:8299.
3. Burgert, H.-G., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987.
4. Andersson, M., S. Pääbo, T. Nilsson, and P. A. Peterson. 1985. Impaired intra-cellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43:215.
5. Andersson, M., A. McMichael, and P. A. Peterson. 1987. Reduced allorecognition of adenovirus-2 infected cells. J. Immunol. 138:3960.
6. Jackson, M. R., T. Nilsson, and P. A. Peterson. 1990. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J. 9:3153.
7. Cox, J. H., J. R. Bennink, and J. W. Yewdell. 1991. Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation. J. Exp. Med. 174:1629.
8. Cox, J. H., J. W. Yewdell, L. C. Eisenlohr, P. R. Johnson, and J. R. Bennink. 1990. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247:715.
9. Beier, D. C., J. H. Cox, D. R. Vining, P. Cresswell, and V. H. Englehard. 1994. Association of human class I MHC alleles with the adenovirus E3/19K protein. J. Immunol. 152:3862.
10. Lehner, P. J., and J. Trowsdale. 1998. Antigen presentation: coming out gracefully. Curr. Biol. 8:R605.
11. Spies, T., V. Cerundolo, M. Colonna, P. Cresswell, A. Townsend, and R. DeMars. 1992. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355:644.
12. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J. Immunol. 142:3320.
13. Greenwood, R., Y. Shimizu, G. S. Sekhon, and R. DeMars. 1994. Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. J. Immunol. 153:5525.
14. Sadasivan, B., P. J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5:103.
15. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14:9.
16. 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864.
17. Hermiston, T. W., R. A. Tripp, T. Sparer, L. R. Gooding, and W. S. M. Wold. 1993. Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. J. Virol. 67:5289.
18. Bresnahan, P. A., L. D. Barber, and F. M. Brodsky. 1997. Localization of class I histocompatibility molecule assembly by subfractionation of the early secretory pathway. Hum. Immunol. 53:129.
19. Smith, G. L., J. Z. Levin, P. Palese, and B. Moss. 1987. Synthesis and cellular location of ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 160:336.
20. Signäs, C., M. G. Katze, H. Persson, and L. Philipson. 1982. An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse. Nature 299:175.
21. Burgert, H.-G., J. L. Maryanski, and S. Kvist. 1987. "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. Proc. Natl. Acad. Sci. USA 84:1356.
22. 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and transporter associated with antigen processing. J. Immunol. 158:2236.
23. Braud, V. M., D. S. J. Allan, D. Wilson, and A. J. McMichael. 1997. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1.
24. Ortmann, B., J. Copeman, P. J. Lehner, B. Sadasivan, J. A. Herberg, A. G. Grandea, S. R. Riddell, R. Tampé, T. Spies, J. Trowsdale, and P. Cresswell. 1997. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277:1306.
25. Burgert, H.-G., and S. Kvist. 1987. The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. EMBO J. 6:2019.
26. Ploegh, H. L. 1998. Viral strategies of immune evasion. Science 280:248.